Biostax CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink

19 Aug 2024

BTAX

10-Q: Biostax Corp Reports Q2 2024 Results with Ongoing Concerns About Financial Stability

Biostax Corp's Q2 2024 report reveals a net loss and negative cash flow, raising substantial doubt about the company's ability to continue as a going concern.

OTC.Pink

19 Aug 2024

BTAX

Biostax CORP

10-Q/A: Biostax Corp Restates Q1 2024 Financials Due to Accounting Errors

Biostax Corp has amended its Q1 2024 quarterly report to correct errors in the calculation of a derivative instrument and related party liabilities.

OTC.Pink

20 May 2024

BTAX

Biostax CORP

10-Q: Biostax Corp Reports First Quarter 2024 Results Amidst Going Concern Uncertainty

Biostax Corp reported a net loss of $337,076 for the first quarter of 2024 and faces significant challenges regarding its ability to continue as a going concern.